More importantly, ORFV NA1/11 treatment significantly increased the frequency of CD8 T cells infiltrates in the tumor tissues, relative to that of the controls (the gating strategy shown in Supplemental Figure S3, Figure 5F). This evidence concerns the gene CD8A and neoplasm.